DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
Prospective Cohort Study of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms and Other Non-Pain Conditions
This study seeks to follow for a period of 1 year all Service members and Veterans at four military treatment facilities who receive stellate ganglion block (SGB) for treatment of Post-Traumatic Stress Disorder (PTSD) or other non-pain conditions. Up to 300 consenting individuals will be enrolled into the cohort; enrollment will last for 18 months. Assessments will be conducted at baseline and one week later, as well as at 2, 4, 6, 9, and 12 months. Outcomes will include symptom trajectory for PTSD and other conditions, changes in neurocognitive functioning, and changes in sleep quality and structure.
Approved For Public Release